These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Value of progestagens in estrogen replacement therapy]. Teter J, Potocki J. Ginekol Pol; 1979 Apr 15; Suppl():286-7. PubMed ID: 548404 [No Abstract] [Full Text] [Related]
6. [Oral hormone therapy in the pre- and postmenopausal period]. Braendle W, Bettendorf G. Gynakologe; 1986 Dec 15; 19(4):235-40. PubMed ID: 3817595 [No Abstract] [Full Text] [Related]
7. Estrogens and progestins: what to use and how to use it. Jones KP. Clin Obstet Gynecol; 1992 Dec 15; 35(4):871-83. PubMed ID: 1451370 [No Abstract] [Full Text] [Related]
8. [Evaluation of hormone replacement therapy in the perimenopause by means of Menopause Rating Scale (MRS I)]. Hauser GA, Ernst U. Zentralbl Gynakol; 1999 Dec 15; 121(11):530-6. PubMed ID: 10612221 [No Abstract] [Full Text] [Related]
9. [Estrogen metabolism and hormone substitution in the climacteric]. Göretzlehner G, Kyank H. Zentralbl Gynakol; 1985 Dec 15; 107(16):977-88. PubMed ID: 2996259 [Abstract] [Full Text] [Related]
10. A rational approach to the use of hormonal replacement therapy in postmenopausal and older women. Terrell D. J Am Board Fam Pract; 1989 Dec 15; 2(2):93-102. PubMed ID: 2652988 [Abstract] [Full Text] [Related]
11. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I]. Savoca S, D'Agosta S, Lombardo G. Minerva Ginecol; 2007 Jun 15; 59(3):205-14. PubMed ID: 17576399 [Abstract] [Full Text] [Related]
13. Prevention of postmenopausal osteoporosis by estrogen/gestagen substitution therapy. Riis B, Christiansen C. Med Klin (Munich); 1987 Mar 20; 82(6):238-41. PubMed ID: 3587168 [No Abstract] [Full Text] [Related]
14. [General undifferentiated estrogen (progestagen) substitution in the prevention of osteoporosis: contra]. Ziegler R. Med Klin (Munich); 1987 Mar 20; 82(6):241-4. PubMed ID: 3587169 [No Abstract] [Full Text] [Related]
15. Norethindrone--a review of therapeutic applications. Taitel HF, Kafrissen ME. Int J Fertil Menopausal Stud; 1995 Mar 20; 40(4):207-23. PubMed ID: 8520623 [Abstract] [Full Text] [Related]
16. [Hormone substitution in climacteric. Position of the German Menopause Society]. Schneider HP, Kuhl H, Dören M, Hesch D. Zentralbl Gynakol; 1995 Mar 20; 117(6):B1-4. PubMed ID: 7645352 [No Abstract] [Full Text] [Related]
17. [Treatment of menopause]. de Lignières B. Soins; 1978 Apr 05; 23(7):27-30. PubMed ID: 249021 [No Abstract] [Full Text] [Related]
18. [Hormone therapy and the risk of cancer in the climacteric]. Kuhl H, Taubert HD. Gynakologe; 1986 Dec 05; 19(4):259-65. PubMed ID: 3817599 [No Abstract] [Full Text] [Related]
19. The practical application of oestrogen-progestogen regimens for pre- and post-menopausal women. Maddison J. Postgrad Med J; 1978 Dec 05; 54 Suppl 2():91. PubMed ID: 740586 [No Abstract] [Full Text] [Related]
20. Clinical effects of 17 beta-estradiol and norethisterone acetate in postmenopausal Thai women. Limpaphayom KK, Bunyavejchevin S. J Med Assoc Thai; 2000 Apr 05; 83(4):407-16. PubMed ID: 10808701 [Abstract] [Full Text] [Related] Page: [Next] [New Search]